Literature DB >> 17241098

Impact of integrated PET/CT on variability of target volume delineation in rectal cancer.

Deep A Patel1, Stephanie T Chang, Karyn A Goodman, Andrew Quon, Brian Thorndyke, Sanjiv S Gambhir, Alex McMillan, Billy W Loo, Albert C Koong.   

Abstract

Several studies have demonstrated substantial variability among individual radiation oncologists in defining target volumes using computed tomography (CT). The objective of this study was to determine the impact of combined positron emission tomography and computed tomography (PET/CT) on inter-observer variability of target volume delineation in rectal cancer. We also compared the relative concordance of two PET imaging tracers, 18F-fluorodeoxyglucose (FDG) and 18F-fluorodeoxythymidine (FLT), against conventional computed tomography (CT). Six consecutive patients with locally advanced rectal cancer were enrolled onto an institutional protocol involving preoperative chemoradiotherapy and correlative studies including FDG- and FLT-PET scans acquired in the treatment position. Using these image data sets, four radiation oncologists independently delineated primary and nodal gross tumor volumes (GTVp and GTVn) for a hypothetical boost treatment. Contours were first defined based on CT alone with observers blinded to the PET images, then based on combined PET/CT. An inter-observer similarity index (SI), ranging from a value of 0 for complete disagreement to 1 for complete agreement of contoured voxels, was calculated for each set of volumes. For primary gross tumor volume (GTVp), the difference in estimated SI between CT and FDG was modest (CT SI = 0.77 vs. FDG SI = 0.81), but statistically significant (p = 0.013). The SI difference between CT and FLT for GTVp was also slight (FLT SI = 0.80) and marginally non-significant (p < 0.082). For nodal gross tumor volume, (GTVn), SI was significantly lower for CT based volumes with an estimated SI of 0.22 compared to an estimated SI of 0.70 for FDG-PET/CT (p < 0.0001) and an estimated SI of 0.70 for FLT-PET/CT (p < 0.0001). Boost target volumes in rectal cancer based on combined PET/CT results in lower inter-observer variability compared with CT alone, particularly for nodal disease. The use of FDG and FLT did not appear to be different from this perspective.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17241098     DOI: 10.1177/153303460700600105

Source DB:  PubMed          Journal:  Technol Cancer Res Treat        ISSN: 1533-0338


  10 in total

Review 1.  PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques.

Authors:  Habib Zaidi; Issam El Naqa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-25       Impact factor: 9.236

2.  FDG-PET/CT imaging for staging and target volume delineation in conformal radiotherapy of anal carcinoma.

Authors:  Marco Krengli; Maria E Milia; Lucia Turri; Eleonora Mones; Maria C Bassi; Barbara Cannillo; Letizia Deantonio; Gianmauro Sacchetti; Marco Brambilla; Eugenio Inglese
Journal:  Radiat Oncol       Date:  2010-02-06       Impact factor: 3.481

Review 3.  Biologically conformal treatment: biomarkers and functional imaging in radiation oncology.

Authors:  Yaacov Richard Lawrence; Maria Werner-Wasik; Adam P Dicker
Journal:  Future Oncol       Date:  2008-10       Impact factor: 3.404

4.  Impact of (18)F-FDG-PET/CT on staging and irradiation of patients with locally advanced rectal cancer.

Authors:  Brigita Paskeviciute; Tobias Bölling; Markus Brinkmann; Ganna Rudykina; Iris Ernst; Lars Stegger; Otmar Schober; Normann Willich; Matthias Weckesser; Stefan Könemann
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

5.  [(18)F]Fluoro-2-deoxy-2-d-glucose versus 3'-deoxy-3'-[(18)F]fluorothymidine for defining hematopoietically active pelvic bone marrow in gynecologic patients.

Authors:  Jeffrey C Wyss; Ruben Carmona; Roshan A Karunamuni; Jakub Pritz; Carl K Hoh; Loren K Mell
Journal:  Radiother Oncol       Date:  2015-12-07       Impact factor: 6.280

Review 6.  Clinical application of multimodality imaging in radiotherapy treatment planning for rectal cancer.

Authors:  Yan Yang Wang; Hong Zhe
Journal:  Cancer Imaging       Date:  2013-12-11       Impact factor: 3.909

Review 7.  Present and future roles of FDG-PET/CT imaging in the management of gastrointestinal cancer: an update.

Authors:  Kazuhiro Kitajima; Masatoyo Nakajo; Hayato Kaida; Ryogo Minamimoto; Kenji Hirata; Masakatsu Tsurusaki; Hiroshi Doi; Yoshiko Ueno; Keitaro Sofue; Yukihisa Tamaki; Koichiro Yamakado
Journal:  Nagoya J Med Sci       Date:  2017-11       Impact factor: 1.131

8.  Target volume delineation of anal cancer based on magnetic resonance imaging or positron emission tomography.

Authors:  Espen Rusten; Bernt Louni Rekstad; Christine Undseth; Ghazwan Al-Haidari; Bettina Hanekamp; Eivor Hernes; Taran Paulsen Hellebust; Eirik Malinen; Marianne Grønlie Guren
Journal:  Radiat Oncol       Date:  2017-09-06       Impact factor: 3.481

9.  Uncertainties in target volume delineation in radiotherapy - are they relevant and what can we do about them?

Authors:  Barbara Segedin; Primoz Petric
Journal:  Radiol Oncol       Date:  2016-05-09       Impact factor: 2.991

10.  Relationship Between 18F-Fluorodeoxyglucose Uptake and V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Mutation in Colorectal Cancer Patients: Variability Depending on C-Reactive Protein Level.

Authors:  Jae-Hoon Lee; Jeonghyun Kang; Seung Hyuk Baik; Kang Young Lee; Beom Jin Lim; Tae Joo Jeon; Young Hoon Ryu; Seung-Kook Sohn
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.